(Q34786104)

4 August 2017

1 reference

title

Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody (English)

1 reference

4 August 2017

1 reference

1 reference

Russell L Dedrick

1

1 reference

4 August 2017

Patricia Walicke

series ordinal

2

1 reference

4 August 2017

Marvin Garovoy

series ordinal

3

1 reference

4 August 2017

publication date

1 May 2002

1 reference

4 August 2017

published in

Transplant Immunology

1 reference

4 August 2017

volume

9

1 reference

4 August 2017

issue

2-4

1 reference

4 August 2017

page(s)

181-186

1 reference

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Chemokines, chemokine receptors, and allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Extracellular matrix proteins in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Potent costimulation of effector T lymphocytes by human collagen type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

The immunological synapse: a molecular machine controlling T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Three-dimensional segregation of supramolecular activation clusters in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

The pathogenesis of psoriasis: immunological facts and speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900029-1

7 January 2021

10.1016/S0966-3274(02)00029-1

Identifiers

DOI

1 reference

4 August 2017

1 reference